Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site - Fierce Biotech
  Notice about the Establishment of the ONO PHARMA Heritage Center - ono-pharma.com
  Ono Pharmaceutical leverages Jorna Therapeutics' AI for next-gen drug discovery - FirstWord Pharma
  Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera - Business Wire
  Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor - MedCity News
  Ono pays $280M to license Ionis rare disease drug - BioPharma Dive
  FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout - Fierce Pharma
  Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation (OTCMKTS:OPHLF) - Seeking Alpha